New tech solutions (ambis #2261864) docusign life sciences premier - 21CFR11, validator and SMS autho, enterprise pro with fedramp - envelope, enterprise premier support with fedramp (annual) esign…

Ended Purchase Order Awarded Last action

Contract number
75N93025P01074
Awardee
Awarding agency
Obligated
$22,215

Award facts

Contract value 100% obligated
$22,214.86 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Competed under SAP · 3 offers Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
North Bethesda, MD 20852, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a purchase order to New TECH Solutions, Inc. for DocuSign Life Sciences Premier software licensing and support services. The contract, valued at $22,214.86 on a firm fixed-price basis, runs from September 1, 2025 through July 26, 2026 and includes DocuSign's 21 CFR Part 11-compliant electronic signature solution with validator and SMS authentication capabilities, enterprise-level functionality, and FedRAMP authorization. The award carries no set-aside designation. Performance will take place in Rockville, Maryland, supporting NIAID's life sciences operations and regulatory compliance requirements for digital documentation and electronic signature processes.

New TECH Solutions, Inc., a small business certified under the 8(a) program and based in Fremont, California, is an established IT solutions provider with extensive experience serving federal agencies since 2002. The company specializes in software licensing, hardware procurement, and enterprise IT support across civilian and defense sectors, with a demonstrated track record of securing contracts through government-wide acquisition contract vehicles such as SEWP V and CIO-CS. This award reflects NIAID's need for enterprise-grade digital signature and document management capabilities that meet stringent federal regulatory standards for life sciences research and operations.

Description

New tech solutions (ambis #2261864) docusign life sciences premier - 21CFR11, validator and SMS autho, enterprise pro with fedramp - envelope, enterprise premier support with fedramp (annual) esign POP 09/01/2025 to 07/26/2026

Quick answers

Who was awarded contract 75N93025P01074?

75N93025P01074 was awarded to New TECH Solutions, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on September 1, 2025.

How much is contract 75N93025P01074 worth?

The government has obligated $22,215 on 75N93025P01074.

Was contract 75N93025P01074 competed?

The extent of competition for 75N93025P01074 was competed under sap. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award